Quanterix Corporation (QTRX)
USD 6.21
(-7.59%)
USD 6.21
(-7.59%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -49.7 Million USD | 31.31% |
| 2022 | -72.35 Million USD | -23.51% |
| 2021 | -58.58 Million USD | -85.49% |
| 2020 | -31.58 Million USD | 24.08% |
| 2019 | -41.6 Million USD | -31.85% |
| 2018 | -31.55 Million USD | -21.32% |
| 2017 | -26 Million USD | -19.78% |
| 2016 | -21.71 Million USD | -49.49% |
| 2015 | -14.52 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -13.1 Million USD | 6.14% |
| 2024 Q1 | -13.96 Million USD | 22.74% |
| 2023 Q1 | -9.45 Million USD | 27.0% |
| 2023 Q2 | -9.56 Million USD | -1.14% |
| 2023 FY | -49.7 Million USD | 31.31% |
| 2023 Q3 | -13.77 Million USD | -44.02% |
| 2023 Q4 | -18.07 Million USD | -31.27% |
| 2022 Q2 | -24.95 Million USD | -37.24% |
| 2022 Q3 | 5.29 Million USD | 121.22% |
| 2022 FY | -72.35 Million USD | -23.51% |
| 2022 Q1 | -18.18 Million USD | 8.59% |
| 2022 Q4 | -12.94 Million USD | -344.46% |
| 2021 Q4 | -19.89 Million USD | -30.61% |
| 2021 Q1 | -9.78 Million USD | 1.45% |
| 2021 Q2 | -13.66 Million USD | -39.63% |
| 2021 FY | -58.58 Million USD | -85.49% |
| 2021 Q3 | -15.23 Million USD | -11.45% |
| 2020 Q4 | -9.93 Million USD | -536.04% |
| 2020 FY | -31.58 Million USD | 24.08% |
| 2020 Q3 | 2.27 Million USD | 118.67% |
| 2020 Q2 | -12.2 Million USD | -4.03% |
| 2020 Q1 | -11.72 Million USD | -2.11% |
| 2019 FY | -41.6 Million USD | -31.85% |
| 2019 Q3 | -10.24 Million USD | 2.58% |
| 2019 Q2 | -10.51 Million USD | -12.37% |
| 2019 Q4 | -11.48 Million USD | -12.14% |
| 2019 Q1 | -9.35 Million USD | 0.59% |
| 2018 Q3 | -7.66 Million USD | -4.8% |
| 2018 Q4 | -9.41 Million USD | -22.85% |
| 2018 FY | -31.55 Million USD | -21.32% |
| 2018 Q1 | -7.16 Million USD | -0.99% |
| 2018 Q2 | -7.31 Million USD | -2.07% |
| 2017 Q4 | -7.09 Million USD | -11.05% |
| 2017 Q1 | -6.05 Million USD | 11.11% |
| 2017 Q2 | -6.46 Million USD | -6.82% |
| 2017 FY | -26 Million USD | -19.78% |
| 2017 Q3 | -6.38 Million USD | 1.27% |
| 2016 Q3 | -5.15 Million USD | 5.01% |
| 2016 Q2 | -5.42 Million USD | -25.82% |
| 2016 Q1 | -4.31 Million USD | 0.0% |
| 2016 FY | -21.71 Million USD | -49.49% |
| 2016 Q4 | -6.81 Million USD | -32.14% |
| 2015 FY | -14.52 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -246.083% |
| Cerus Corporation | -30.05 Million USD | -65.378% |
| OrthoPediatrics Corp. | -25.76 Million USD | -92.894% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -367.935% |
| Talis Biomedical Corporation | -66.81 Million USD | 25.614% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -187.355% |
| Inogen, Inc. | -109.38 Million USD | 54.564% |
| Spectral AI, Inc. | -12.98 Million USD | -282.787% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 20.591% |
| CVRx, Inc. | -43.1 Million USD | -15.308% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -1308.759% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -299.911% |
| Orthofix Medical Inc. | -139.11 Million USD | 64.272% |
| Venus Concept Inc. | -28.3 Million USD | -75.566% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 8.009% |
| Bioventus Inc. | -81.72 Million USD | 39.185% |
| BrainsWay Ltd. | -4.92 Million USD | -908.748% |
| Envoy Medical, Inc. | -18.37 Million USD | -170.541% |
| electroCore, Inc. | -18.8 Million USD | -164.297% |
| IceCure Medical Ltd | -15.57 Million USD | -219.087% |
| Lucid Diagnostics Inc. | -48.48 Million USD | -2.514% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -187.821% |
| MaxCyte, Inc. | -48.29 Million USD | -2.903% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -315.725% |
| Nexalin Technology, Inc. | -5.69 Million USD | -772.514% |
| PAVmed Inc | -68.79 Million USD | 27.755% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 12.132% |
| RxSight, Inc. | -50.08 Million USD | 0.767% |
| Sight Sciences, Inc. | -57.27 Million USD | 13.222% |
| SI-BONE, Inc. | -46.93 Million USD | -5.902% |
| TELA Bio, Inc. | -44.07 Million USD | -12.765% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 8.216% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 3.358% |
| LivaNova PLC | -68.49 Million USD | 27.442% |
| 908 Devices Inc. | -42.75 Million USD | -16.238% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 71.337% |
| Nemaura Medical Inc. | -9.59 Million USD | -417.976% |
| NeuroPace, Inc. | -27.17 Million USD | -82.899% |
| LENSAR, Inc. | -12.22 Million USD | -306.419% |
| Apyx Medical Corporation | -17.25 Million USD | -187.971% |
| Cutera, Inc. | -156.23 Million USD | 68.187% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -477.65% |
| BioSig Technologies, Inc. | -28.51 Million USD | -74.316% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 43.289% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -121.425% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 144.564% |
| Axonics, Inc. | -26.05 Million USD | -90.74% |
| Outset Medical, Inc. | -169.77 Million USD | 70.725% |
| IRIDEX Corporation | -10 Million USD | -396.662% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 54.474% |
| IRadimed Corporation | 20.03 Million USD | 348.065% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -502.802% |
| INVO Bioscience, Inc. | -6.76 Million USD | -634.445% |
| Telesis Bio, Inc. | -35.15 Million USD | -41.397% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 446.832% |
| Varex Imaging Corporation | 32.1 Million USD | 254.832% |
| Quipt Home Medical Corp. | 3.91 Million USD | 1368.206% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -309.635% |
| Pulmonx Corporation | -61.93 Million USD | 19.753% |
| Dynatronics Corporation | -2.27 Million USD | -2086.535% |
| Modular Medical, Inc. | -17.52 Million USD | -183.536% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -239.511% |
| Semler Scientific, Inc. | 22.25 Million USD | 323.315% |
| InMode Ltd. | 195.66 Million USD | 125.402% |
| Bruker Corporation | 436.9 Million USD | 111.376% |
| Cytosorbents Corporation | -31.2 Million USD | -59.251% |
| DexCom, Inc. | 597.7 Million USD | 108.315% |
| Align Technology, Inc. | 643.33 Million USD | 107.725% |
| Viveve Medical, Inc. | -21.55 Million USD | -130.599% |
| ZimVie Inc. | -30.93 Million USD | -60.642% |
| Movano Inc. | -29.69 Million USD | -67.4% |
| Cytek Biosciences, Inc. | -27.84 Million USD | -78.492% |
| Nexalin Technology, Inc. | -5.69 Million USD | -772.514% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -1308.759% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 78.69% |
| Profound Medical Corp. | -28.61 Million USD | -73.683% |
| Insulet Corporation | 220 Million USD | 122.591% |
| enVVeno Medical Corporation | -25.23 Million USD | -96.929% |
| Surmodics, Inc. | -5.64 Million USD | -780.443% |
| iCAD, Inc. | -7.68 Million USD | -546.391% |
| Nuwellis, Inc. | -17.63 Million USD | -181.912% |
| Biotricity, Inc. | -8.82 Million USD | -462.976% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 60.29% |
| Aethlon Medical, Inc. | -12.63 Million USD | -293.311% |
| InspireMD, Inc. | -21.14 Million USD | -135.071% |
| PAVmed Inc. | -68.79 Million USD | 27.755% |
| BIOLASE, Inc. | -17.93 Million USD | -177.086% |
| Beyond Air, Inc. | -63 Million USD | 21.117% |
| FONAR Corporation | 16.53 Million USD | 400.574% |
| AxoGen, Inc. | -21.46 Million USD | -131.577% |
| Vivani Medical, Inc. | -26.96 Million USD | -84.317% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 375.489% |
| Inari Medical, Inc. | -14.03 Million USD | -254.198% |
| UFP Technologies, Inc. | 57.66 Million USD | 186.191% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -908.625% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -688.183% |
| Tenon Medical, Inc. | -15.72 Million USD | -216.023% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -564.985% |
| Co-Diagnostics, Inc. | -42.7 Million USD | -16.379% |
| AdaptHealth Corp. | -598.4 Million USD | 91.694% |
| Sintx Technologies, Inc. | -13.35 Million USD | -272.069% |
| NanoVibronix, Inc. | -3.43 Million USD | -1346.478% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -309.635% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -12910.733% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 85.14% |
| TransMedics Group, Inc. | -28.72 Million USD | -73.011% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -110.49% |
| NeuroMetrix, Inc. | -7.15 Million USD | -594.971% |
| Hyperfine, Inc. | -48.11 Million USD | -3.296% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 23.567% |
| Biomerica, Inc. | -6.36 Million USD | -680.603% |
| Bone Biologics Corporation | -9.42 Million USD | -427.147% |
| AVITA Medical, Inc. | -40.4 Million USD | -23.016% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -382.009% |
| Silk Road Medical, Inc | -59.27 Million USD | 16.146% |